Professor Yoni Freedhoff claimed that changing eating and exercise habits will never be as effective as weight-loss drugs ...

Health secretary Wes Streeting has backed the prescribing of the drugs to obese patients in the hope it can tackle the nation ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Eli Lilly continues to break new ground. Its famous weight loss medicine, Zepbound (tirzepatide), just became the first to ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

No one has ever known so much about healthy eating and been less successful at following her own advice.